Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LAM”

564 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 564 results

Large-scale testing (Phase 3)UnknownNCT01270165
What this trial is testing

Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Yonsei University 110
Not applicableUnknownNCT03694600
What this trial is testing

Clinical Trial Multi-analyte Blood Test

Who this might be right for
Liver Cirrhosis
Helio Genomics 1,900
Post-approval studies (Phase 4)Study completedNCT00192621
What this trial is testing

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Who this might be right for
HIV InfectionsDyslipidemiasGlucose Metabolism Disorders+3 more
Kirby Institute 50
Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Large-scale testing (Phase 3)Study completedNCT03016533
What this trial is testing

Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

Who this might be right for
HIV Infections
ViiV Healthcare 100
Post-approval studies (Phase 4)Study completedNCT04549467
What this trial is testing

Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test

Who this might be right for
HivHIV-1-infection
Fundacion IDEAA 244
Post-approval studies (Phase 4)Study completedNCT01088009
What this trial is testing

Efficacy Optimizing Research of Lamivudine Therapy

Who this might be right for
Compensated Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 366
Post-approval studies (Phase 4)Study completedNCT00127972
What this trial is testing

2NN & CHARM Long-Term Follow-up Study

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 763
Post-approval studies (Phase 4)Study completedNCT04880395
What this trial is testing

Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Who this might be right for
HIV-1-infection
Fundación Huésped 265
Post-approval studies (Phase 4)Study completedNCT00338780
What this trial is testing

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong
Not applicableStudy completedNCT00001075
What this trial is testing

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT01077557
What this trial is testing

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Who this might be right for
FractureInfection, Human Immunodeficiency Virus
ViiV Healthcare 1
Large-scale testing (Phase 3)Study completedNCT02831764
What this trial is testing

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 722
Post-approval studies (Phase 4)WithdrawnNCT00986778
What this trial is testing

Entecavir Plus Adefovir in Lamivudine-Resistant Patients

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT03441984
What this trial is testing

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 36
Not applicableNot Yet RecruitingNCT06019052
What this trial is testing

Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study

Who this might be right for
Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,890
Testing effectiveness (Phase 2)Looking for participantsNCT06034938
What this trial is testing

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

Who this might be right for
Hiv
University Hospital, Caen 32
Testing effectiveness (Phase 2)Ended earlyNCT00040144
What this trial is testing

Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Alexion Pharmaceuticals, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT00128193
What this trial is testing

Leprosy Skin Test Antigens Trial

Who this might be right for
Leprosy
National Institute of Allergy and Infectious Diseases (NIAID) 260
Post-approval studies (Phase 4)Study completedNCT01818258
What this trial is testing

IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children

Who this might be right for
HIV PositiveMalnourished
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 52
Load More Results